The Patent Finder

Avadel Legacy Pharmaceuticals, LLC

Also on record
Records under this name other than the patents Avadel Legacy Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 9 of 9 · Back to Avadel Legacy Pharmaceuticals, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,493,051Cysteine Composition and Injection
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,543,186Cysteine Composition and Injection
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,702,490Cysteine Composition and Injection
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,045,438Cysteine Composition and Injection
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,906,145Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S)
Term ended
Term ended Sep 26, 2025 · High confidence
Term endedTerm ended Sep 26, 2025High confidence
US 7,683,024Polyaminoacids Functionalized by Alpha Tocopherol and Uses Thereof, Particular for Therapeutic Applications
Term ended
Term ended Jul 19, 2023 · High confidence
Term endedTerm ended Jul 19, 2023High confidence
US 9,814,684Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S)
Term ended
Term ended Apr 7, 2023 · Medium confidence
Term endedTerm ended Apr 7, 2023Medium confidence
US 10,004,693Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S)
Term ended
Ended no later than Apr 7, 2023 · Medium confidence
Term endedEnded no later than Apr 7, 2023Medium confidence
US 8,679,540Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
Surrendered on reissue
Surrendered on reissue Jan 30, 2018 · Low confidence
Surrendered on reissueSurrendered on reissue Jan 30, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited